Sid Suggs

3.6k total citations · 1 hit paper
8 papers, 2.8k citations indexed

About

Sid Suggs is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Sid Suggs has authored 8 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Sid Suggs's work include Genetic factors in colorectal cancer (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Ubiquitin and proteasome pathways (2 papers). Sid Suggs is often cited by papers focused on Genetic factors in colorectal cancer (3 papers), Colorectal Cancer Treatments and Studies (3 papers) and Ubiquitin and proteasome pathways (2 papers). Sid Suggs collaborates with scholars based in United States, Canada and Belgium. Sid Suggs's co-authors include Todd Juan, Michael Wolf, Daniel J. Freeman, Scott D. Patterson, Marc Peeters, David Chang, Robert Radinsky, Eric Van Cutsem, Rafael G. Amado and Robert Sikorski and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Biochemical and Biophysical Research Communications.

In The Last Decade

Sid Suggs

8 papers receiving 2.7k citations

Hit Papers

Wild-Type KRAS Is Required for Panitumumab Efficacy in Pa... 2008 2026 2014 2020 2008 500 1000 1.5k 2.0k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sid Suggs United States 8 2.1k 868 830 646 634 8 2.8k
Katia Bencardino Italy 24 1.8k 0.8× 669 0.8× 806 1.0× 592 0.9× 591 0.9× 77 2.4k
Silvia Benvenuti Italy 20 1.6k 0.8× 586 0.7× 923 1.1× 969 1.5× 436 0.7× 40 2.6k
Maria Błasińska-Morawiec Poland 17 1.7k 0.8× 760 0.9× 897 1.1× 364 0.6× 337 0.5× 37 2.5k
Emily Chan United States 20 2.1k 1.0× 471 0.5× 762 0.9× 1.1k 1.7× 420 0.7× 46 2.9k
Vinod Ganju Australia 24 2.0k 0.9× 316 0.4× 906 1.1× 655 1.0× 447 0.7× 94 2.7k
Syma Iqbal United States 29 2.0k 0.9× 539 0.6× 993 1.2× 901 1.4× 358 0.6× 129 3.1k
J. Randolph Hecht United States 22 2.8k 1.3× 617 0.7× 1.9k 2.2× 949 1.5× 501 0.8× 78 4.2k
Guillem Argilés Spain 24 1.8k 0.8× 621 0.7× 602 0.7× 719 1.1× 422 0.7× 95 2.5k
Johannes Nippgen Germany 15 3.2k 1.5× 922 1.1× 1.4k 1.7× 782 1.2× 629 1.0× 27 4.3k

Countries citing papers authored by Sid Suggs

Since Specialization
Citations

This map shows the geographic impact of Sid Suggs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sid Suggs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sid Suggs more than expected).

Fields of papers citing papers by Sid Suggs

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sid Suggs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sid Suggs. The network helps show where Sid Suggs may publish in the future.

Co-authorship network of co-authors of Sid Suggs

This figure shows the co-authorship network connecting the top 25 collaborators of Sid Suggs. A scholar is included among the top collaborators of Sid Suggs based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sid Suggs. Sid Suggs is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Amado, Rafael G., Michael Wolf, Marc Peeters, et al.. (2023). Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer. Journal of Clinical Oncology. 41(18). 3278–3286. 15 indexed citations
2.
Oliner, Kelly S., Todd Juan, Sid Suggs, et al.. (2010). A comparability study of 5 commercial KRAS tests. Diagnostic Pathology. 5(1). 23–23. 44 indexed citations
3.
Thomas, John, et al.. (2009). Utility of lyophilized PMA and ionomycin to stimulate lymphocytes in whole blood for immunological assays. Cytometry Part B Clinical Cytometry. 78B(1). 59–64. 10 indexed citations
4.
Amado, Rafael G., Michael Wolf, Marc Peeters, et al.. (2008). Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer. Journal of Clinical Oncology. 26(10). 1626–1634. 2400 indexed citations breakdown →
6.
Snow, Bryan E., et al.. (1997). Molecular Cloning and Expression Analysis of RatRgs12andRgs14. Biochemical and Biophysical Research Communications. 233(3). 770–777. 106 indexed citations
7.
Grossman, Alex, Hans-Willi Mittrücker, Jillian Nicholl, et al.. (1996). Cloning of Human Lymphocyte-Specific Interferon Regulatory Factor (hLSIRF/hIRF4) and Mapping of the Gene to 6p23–p25. Genomics. 37(2). 229–233. 68 indexed citations
8.
Chang, Ming‐Shi, Jennifer McNinch, R Basu, et al.. (1995). Cloning and Characterization of the Human Megakaryocyte Growth and Development Factor (MGDF) Gene. Journal of Biological Chemistry. 270(2). 511–514. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026